After 33 years Geron could have an approved drug

[cafead]

via The strange journey of Geron’s telomerase inhibitor imetelstat is reaching a conclusion, nine years after a controversial haematologist endorsed the project’s use in myelofibrosis. Today the group toplined imetelstat’s phase 3 Imerge study as positive, setting the stage for a filing later this year in low-risk myelodysplastic syndromes.

article source